跳转至内容
Merck
所有图片(1)

Key Documents

F6754

Sigma-Aldrich

铁蛋白 来源于人类肝脏

Type IV, 10 μg/mL

登录查看公司和协议定价


About This Item

CAS号:
MDL號碼:
分類程式碼代碼:
12352202
NACRES:
NA.61

生物源

human liver

品質等級

無菌

0.2 μm filtered

種類

Type IV

化驗

≥95% (SDS-GE)

形狀

liquid

分子量

H subunit ~21 kDa
L subunit ~19 kDa
~440 kDa (a shell of 24 protein subunits (apoferritin) and a core of Fe3+ ions)

包裝

vial of 2 μg

濃度

10 μg/mL

UniProt登錄號

儲存溫度

2-8°C

基因資訊

一般說明

铁蛋白包含24个亚基,属于铁蛋白样双铁羧酸蛋白质超家族。铁蛋白由重链(H)和轻链(L)亚基组成。肝铁蛋白主要由轻链亚基组成,脾为重链。轻链亚基定位于人染色体9q13.33, 重链为11q12.3。

應用

人肝脏铁蛋白已用作体积排阻高效液相色谱中的蛋白模型,并用于合成纳米孔转位研究。还用于检测其对虾(凡纳滨对虾/Litopenaeus vannamei)的白斑综合征病毒易感性的影响。

生化/生理作用

广泛的储铁蛋白在铁代谢中起关键作用。其用作细胞内的铁储备(特别是在脾脏、肝脏、肠粘膜和骨髓中)并参与铁解毒。 研究表明,铁蛋白铁的掺入是由与铁蛋白 H 亚基相关的铁氧化酶活性和与铁蛋白 L 亚基相关的成核中心介导的。 从铁蛋白释放铁在铁依赖性脂质过氧化中具有重要作用,并且可能在体内促成自由基诱导的细胞损伤。因此,通过结合铁,铁蛋白可以起抗氧化剂的作用。
铁蛋白是宿主防御体系的一部分,在动物的抗病毒感染应答中起作用。铁蛋白的异常水平与前列腺、乳腺和大脑等多个部位的肿瘤有关。炎症和巨噬细胞活化综合征(MAS)会导致铁蛋白浓度升高。轻链亚基突变会导致神经退行性疾病、遗传性铁蛋白病。

外觀

溶液,pH 8.0,含10 mM Tris、150 mM NaCl和0.1%叠氮化钠。

儲存類別代碼

10 - Combustible liquids

水污染物質分類(WGK)

WGK 1

閃點(°F)

Not applicable

閃點(°C)

Not applicable


分析证书(COA)

输入产品批号来搜索 分析证书(COA) 。批号可以在产品标签上"批“ (Lot或Batch)字后找到。

已有该产品?

在文件库中查找您最近购买产品的文档。

访问文档库

Yuan-Hwa Ruan et al.
Fish & shellfish immunology, 28(4), 542-548 (2010-01-05)
We examined the physiological (hemolymph glucose, lactate, and lipid) and innate non-specific immune responses (total hemocyte count (THC), phenoloxidase (PO) activity, respiratory bursts (release of superoxide anion, O(2)(-)) and superoxide dismutase (SOD) activity) to white spot syndrome virus (WSSV) in
P Ruscitti et al.
Clinical and experimental immunology, 191(2), 220-228 (2017-09-30)
Macrophage activation syndrome (MAS) is hyperinflammatory life-threatening syndrome, associated typically with high levels of serum ferritin. This is an iron storage protein including heavy (H) and light (L) subunits, categorized on their molecular weight. The H-/L subunits ratio may be
Ann Kruger et al.
Nephrology nursing journal : journal of the American Nephrology Nurses' Association, 40(2), 135-139 (2013-06-19)
This study examined whether a change infrequency of administration of erythropoietin-stimulating agent affected hemoglobin levels in patients on peritoneal dialysis. Data were extracted from the Australian Renal Anaemia Management database for the years 2002 and 2008. Less frequent dosing and
Rachel Collings et al.
The American journal of clinical nutrition, 98(1), 65-81 (2013-05-31)
Absorption factors are required to convert physiologic requirements for iron into Dietary Reference Values, but the absorption from single meals cannot be used to estimate dietary iron absorption. The objective was to conduct a systematic review of iron absorption from
Aurélie A Righetti et al.
The American journal of clinical nutrition, 97(6), 1364-1374 (2013-04-26)
Iron deficiency (ID) is a major cause of anemia, along with other nutritional, parasitic, and genetic factors. Accurate biomarkers are needed to estimate the relative contribution of ID to anemia. Soluble transferrin receptor (sTfR) is thought to be unaffected by

我们的科学家团队拥有各种研究领域经验,包括生命科学、材料科学、化学合成、色谱、分析及许多其他领域.

联系技术服务部门